A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects.

MLA

Matloka, Mikolaj, et al. “A PDE10A Inhibitor CPL500036 Is a Novel Agent Modulating Striatal Function Devoid of Most Neuroleptic Side-Effects.” Frontiers in Pharmacology, vol. 13, Nov. 2022, p. 999685. EBSCOhost, https://doi.org/10.3389/fphar.2022.999685.

APA

Matloka, M., Janowska, S., Pankiewicz, P., Kokhanovska, S., Kos, T., Hołuj, M., Rutkowska-Wlodarczyk, I., Abramski, K., Janicka, M., Jakubowski, P., Świątkiewicz, M., Welniak-Kaminska, M., Hucz-Kalitowska, J., Dera, P., Bojarski, L., Grieb, P., Popik, P., Wieczorek, M., & Pieczykolan, J. (2022). A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects. Frontiers in Pharmacology, 13, 999685. https://doi.org/10.3389/fphar.2022.999685

Chicago

Matloka, Mikolaj, Sylwia Janowska, Piotr Pankiewicz, Sofiya Kokhanovska, Tomasz Kos, Małgorzata Hołuj, Izabela Rutkowska-Wlodarczyk, et al. 2022. “A PDE10A Inhibitor CPL500036 Is a Novel Agent Modulating Striatal Function Devoid of Most Neuroleptic Side-Effects.” Frontiers in Pharmacology 13 (November): 999685. doi:10.3389/fphar.2022.999685.